Search results
Born to run: Brooklyn man diagnosed with rare disease is back doing what he loves
News 12 New Jersey· 3 days agoA Brooklyn man diagnosed with a rare autoimmune condition has not let it get in the way of his love for running. Michael Ring ran many marathons until 2014. Days later, he was placed in a hospital ...
‘Where Did Justine Go?’ One Woman Disappears Into Devotion
New York Times· 21 hours agoA few days before Christmas in 2020, quarantined with Covid in the basement of a Hare Krishna ashram...
Lizz Russell Unveils The Glamorous 12th Annual Cocktails & Couture Charity Fashion Show, Celebrating...
KPBS San Diego· 5 days agoGet ready for an extraordinary event that will dazzle your senses and touch your heart! The renowned...
The Making Of ‘Illinoise’ And The Guiding Vision Of Sufjan Stevens – Tony Watch Q&A With Justin Peck
Deadline via Yahoo News· 6 days agoIllinoise, the dance-musical hybrid nominated for four Tony Awards (including Best Musical) is the...
ICMR rejects BHU study on Covaxin, says findings misleading
Investing.com· 3 days agoICMR rejects BHU study on Covaxin, says findings misleading
Hansa Biopharma to present data at 2024 American Transplant Congress annual meeting
FOX 16 Little Rock· 2 days agoHansa Biopharma, "Hansa" (NASDAQ: HNSA) (STOCKHOLM: HNSA), today announced data featuring imlifidase...
Norma Burnham
The Gazette· 1 day agoNorma Burnham Atlantic Norma Burnham was born to Otto and Alma (Paxson) Mortensen in Coon Rapids, IA on August 24, …
Akari Therapeutics (NASDAQ:AKTX) Coverage Initiated at StockNews.com
ETF DAILY NEWS· 3 days agoInvestment analysts at StockNews.com initiated coverage on shares of Akari Therapeutics (NASDAQ:AKTX – Get Free Report) in a research note issued to investors on Saturday. The brokerage set ...
Annexon, Inc. (NASDAQ:ANNX) Receives $14.14 Average Price Target from Analysts
ETF DAILY NEWS· 3 days agoShares of Annexon, Inc. (NASDAQ:ANNX – Get Free Report) have earned an average recommendation of “Buy” from the six research firms that are presently covering the stock, MarketBeat reports.
Cantor Fitzgerald Comments on Annexon, Inc.’s FY2024 Earnings (NASDAQ:ANNX)
ETF DAILY NEWS· 5 days agoAnnexon, Inc. (NASDAQ:ANNX – Free Report) – Stock analysts at Cantor Fitzgerald boosted their FY2024 earnings estimates for shares of Annexon in a research note issued on Tuesday, May 14th.
